ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| Share Capital | ₹11 Cr | ₹4.01 Cr | ₹4.01 Cr |
| Equity - Authorised | ₹15 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity - Issued | ₹11 Cr | ₹4.16 Cr | ₹4.16 Cr |
| Equity Paid Up | ₹11 Cr | ₹4.01 Cr | ₹4.01 Cr |
| Equity Shares Forfeited | - | - | - |
| Adjustments to Equity | - | - | - |
| Preference Capital Paid Up | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | ₹12 Cr | ₹7.92 Cr | ₹5.96 Cr |
| Total Reserves | ₹5,896 Cr | ₹386 Cr | ₹777 Cr |
| Securities Premium | ₹7,698 Cr | ₹2,204 Cr | ₹2,204 Cr |
| Capital Reserves | - | - | - |
| Profit & Loss Account Balance | ₹-1,802 Cr | ₹-1,818 Cr | ₹-1,427 Cr |
| General Reserves | - | - | - |
| Other Reserves | - | - | - |
| Reserve excluding Revaluation Reserve | ₹5,896 Cr | ₹386 Cr | ₹777 Cr |
| Revaluation reserve | - | - | - |
| Shareholder's Funds | ₹5,920 Cr | ₹398 Cr | ₹787 Cr |
| Minority Interest | - | - | - |
| Long-Term Borrowings | - | - | - |
| Secured Loans | ₹181 Cr | ₹12 Cr | ₹285 Cr |
| Non Convertible Debentures | ₹98 Cr | - | - |
| Converible Debentures & Bonds | - | - | - |
| Packing Credit - Bank | - | - | - |
| Inter Corporate & Security Deposit | - | - | - |
| Term Loans - Banks | ₹200 Cr | ₹168 Cr | ₹593 Cr |
| Term Loans - Institutions | - | - | - |
| Other Secured | ₹-116 Cr | ₹-156 Cr | ₹-308 Cr |
| Unsecured Loans | ₹38 Cr | ₹259 Cr | ₹50 Cr |
| Fixed Deposits - Public | - | - | - |
| Loans and advances from subsidiaries | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - |
| Foreign Currency Convertible Notes | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - |
| Loans - Banks | - | - | - |
| Loans - Govt. | - | - | - |
| Loans - Others | ₹46 Cr | ₹50 Cr | - |
| Other Unsecured Loan | ₹-7.67 Cr | ₹210 Cr | ₹50 Cr |
| Deferred Tax Assets / Liabilities | - | - | - |
| Deferred Tax Assets | ₹124 Cr | ₹111 Cr | - |
| Deferred Tax Liability | ₹124 Cr | ₹111 Cr | - |
| Other Long Term Liabilities | ₹166 Cr | ₹8.32 Cr | ₹21 Cr |
| Long Term Trade Payables | - | - | - |
| Long Term Provisions | ₹16 Cr | ₹2.40 Cr | ₹2.15 Cr |
| Total Non-Current Liabilities | ₹401 Cr | ₹282 Cr | ₹358 Cr |
| Current Liabilities | - | - | - |
| Trade Payables | ₹160 Cr | ₹81 Cr | ₹95 Cr |
| Sundry Creditors | ₹160 Cr | ₹81 Cr | ₹95 Cr |
| Acceptances | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - |
| Other Current Liabilities | ₹483 Cr | ₹534 Cr | ₹571 Cr |
| Bank Overdraft / Short term credit | - | - | - |
| Advances received from customers | ₹228 Cr | ₹86 Cr | ₹54 Cr |
| Interest Accrued But Not Due | ₹13 Cr | ₹20 Cr | ₹8.82 Cr |
| Share Application Money | - | - | - |
| Current maturity of Debentures & Bonds | ₹48 Cr | ₹125 Cr | - |
| Current maturity - Others | - | - | - |
| Other Liabilities | ₹195 Cr | ₹303 Cr | ₹508 Cr |
| Short Term Borrowings | ₹414 Cr | ₹9.00 Cr | ₹194 Cr |
| Secured ST Loans repayable on Demands | ₹406 Cr | - | ₹98 Cr |
| Working Capital Loans- Sec | ₹406 Cr | - | ₹98 Cr |
| Buyers Credits - Unsec | - | - | - |
| Commercial Borrowings- Unsec | - | - | - |
| Other Unsecured Loans | ₹-399 Cr | ₹9.00 Cr | ₹-2.90 Cr |
| Short Term Provisions | ₹12 Cr | ₹4.30 Cr | ₹3.58 Cr |
| Proposed Equity Dividend | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - |
| Provision for Tax | - | - | - |
| Provision for post retirement benefits | - | - | - |
| Preference Dividend | - | - | - |
| Other Provisions | ₹12 Cr | ₹4.30 Cr | ₹3.58 Cr |
| Total Current Liabilities | ₹1,069 Cr | ₹629 Cr | ₹864 Cr |
| Total Liabilities | ₹7,390 Cr | ₹1,309 Cr | ₹2,008 Cr |
| ASSETS | |||
| Gross Block | ₹3,611 Cr | ₹1,139 Cr | ₹1,633 Cr |
| Less: Accumulated Depreciation | ₹410 Cr | ₹277 Cr | ₹271 Cr |
| Less: Impairment of Assets | - | - | - |
| Net Block | ₹3,200 Cr | ₹863 Cr | ₹1,361 Cr |
| Lease Adjustment A/c | - | - | - |
| Capital Work in Progress | ₹60 Cr | ₹43 Cr | ₹191 Cr |
| Non Current Investments | ₹2,839 Cr | ₹3.91 Cr | ₹0.01 Cr |
| Long Term Investment | ₹2,839 Cr | ₹3.91 Cr | ₹0.01 Cr |
| Quoted | - | - | - |
| Unquoted | ₹2,889 Cr | ₹42 Cr | ₹52 Cr |
| Long Term Loans & Advances | ₹121 Cr | ₹77 Cr | ₹82 Cr |
| Other Non Current Assets | ₹0.41 Cr | ₹0.80 Cr | ₹2.42 Cr |
| Total Non-Current Assets | ₹6,367 Cr | ₹1,132 Cr | ₹1,780 Cr |
| Current Assets Loans & Advances | - | - | - |
| Currents Investments | ₹8.88 Cr | ₹16 Cr | ₹4.50 Cr |
| Quoted | ₹8.88 Cr | ₹16 Cr | ₹4.50 Cr |
| Unquoted | - | - | - |
| Inventories | ₹153 Cr | ₹11 Cr | ₹133 Cr |
| Raw Materials | ₹104 Cr | ₹73 Cr | ₹73 Cr |
| Work-in Progress | ₹8.23 Cr | - | - |
| Finished Goods | ₹7.91 Cr | - | - |
| Packing Materials | - | - | - |
| Stores  and Spare | ₹140 Cr | ₹56 Cr | - |
| Other Inventory | ₹-107 Cr | ₹-117 Cr | ₹60 Cr |
| Sundry Debtors | ₹442 Cr | ₹55 Cr | ₹3.74 Cr |
| Debtors more than Six months | ₹53 Cr | ₹17 Cr | ₹14 Cr |
| Debtors Others | ₹402 Cr | ₹48 Cr | ₹3.71 Cr |
| Cash and Bank | ₹228 Cr | ₹60 Cr | ₹80 Cr |
| Cash in hand | ₹0.07 Cr | ₹0.00 Cr | ₹0.07 Cr |
| Balances at Bank | ₹228 Cr | ₹60 Cr | ₹80 Cr |
| Other cash and bank balances | - | - | - |
| Other Current Assets | ₹37 Cr | ₹8.07 Cr | ₹1.04 Cr |
| Interest accrued on Investments | - | - | - |
| Interest accrued on Debentures | - | - | - |
| Deposits with Government | - | - | - |
| Interest accrued and or due on loans | ₹1.72 Cr | - | - |
| Prepaid Expenses | ₹10 Cr | ₹3.07 Cr | ₹1.04 Cr |
| Other current_assets | ₹25 Cr | ₹5.00 Cr | - |
| Short Term Loans and Advances | ₹155 Cr | ₹26 Cr | ₹6.02 Cr |
| Advances recoverable in cash or in kind | ₹64 Cr | ₹26 Cr | ₹18 Cr |
| Advance income tax and TDS | ₹21 Cr | ₹14 Cr | ₹2.53 Cr |
| Amounts due from directors | - | - | - |
| Due From Subsidiaries | - | - | - |
| Inter corporate deposits | - | - | - |
| Corporate Deposits | - | - | - |
| Other Loans & Advances | ₹70 Cr | ₹-14 Cr | ₹-14 Cr |
| Total Current Assets | ₹1,024 Cr | ₹176 Cr | ₹228 Cr |
| Net Current Assets (Including Current Investments) | ₹-46 Cr | ₹-452 Cr | ₹-635 Cr |
| Miscellaneous Expenses not written off | - | - | - |
| Total Assets | ₹7,390 Cr | ₹1,309 Cr | ₹2,008 Cr |
| Contingent Liabilities | - | - | ₹23 Cr |
| Total Debt | ₹772 Cr | ₹562 Cr | ₹837 Cr |
| Book Value | 516.29 | 97.21 | 194.70 |
| Adjusted Book Value | 516.29 | 97.21 | 194.70 |
Compare Balance Sheet of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹21,257.5 Cr | 2.7% | 1.2% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.7% |
1.2% |
|
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses